Company / SG&A per Share
Insulet Corporation SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$16.60
FY2025
5-year range
$7.06 / $16.60
FY2021-FY2025
Trend
+26.5%
vs FY2024
Sector context
#30 of 150
Health Care
What the data says
Insulet Corporation's sg&a per share of $16.60 is higher than 80% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 9 consecutive years, from $1.26 in FY2016 to $16.60 in FY2025.
Based on SEC 10-K filings.
16.60 in FY2025 with a 5-year CAGR of +22.1%. Top quartile in the Health Care sector.
Increased from $10.57 to $16.60 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +25.0%
- 5-Year CAGR
- +22.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 150This company $16.60 Sector average $11878.17
▼
-99.9% below sector average
Key checks
Key Insights
- Insulet Corporation's sg&a per share has grown for 9 consecutive years.
- In FY2025, sg&a per share increased 26.5% year-over-year.
- Ranks #30 out of 150 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.60 | +26.5% |
| FY2024 | $13.12 | +24.1% |
| FY2023 | $10.57 | +24.4% |
| FY2022 | $8.50 | +20.4% |
| FY2021 | $7.06 | +15.2% |
| FY2020 | $6.13 | +21.7% |
| FY2019 | $5.03 | +18.4% |
| FY2018 | $4.25 | +188.5% |
| FY2017 | $1.47 | +17.3% |
| FY2016 | $1.26 | +17.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026